Compare AANJANEYA LIFECARE with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ALEMBIC LTD DR. DATSONS LABS/
ALEMBIC LTD
 
P/E (TTM) x -10.9 74.6 - View Chart
P/BV x 0.2 2.6 6.1% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 DR. DATSONS LABS   ALEMBIC LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ALEMBIC LTD
Mar-18
DR. DATSONS LABS/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs12672 174.4%   
Low Rs3134 91.2%   
Sales per share (Unadj.) Rs133.04.7 2,829.2%  
Earnings per share (Unadj.) Rs0.26.1 2.5%  
Cash flow per share (Unadj.) Rs6.66.2 105.8%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs128.840.7 316.7%  
Shares outstanding (eoy) m31.66267.03 11.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.611.3 5.2%   
Avg P/E ratio x516.18.7 5,949.4%  
P/CF ratio (eoy) x11.88.5 139.7%  
Price / Book Value ratio x0.61.3 46.7%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m2,47714,139 17.5%   
No. of employees `000NANA-   
Total wages/salary Rs m56207 27.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,2111,255 335.4%  
Other income Rs m79370 21.3%   
Total revenues Rs m4,2891,625 263.9%   
Gross profit Rs m569111 511.8%  
Depreciation Rs m20438 540.7%   
Interest Rs m4302 25,305.9%   
Profit before tax Rs m13442 2.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21,212 -0.1%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624 25.5%   
Profit after tax Rs m51,630 0.3%  
Gross profit margin %13.58.9 152.6%  
Effective tax rate %48.05.4 886.0%   
Net profit margin %0.1129.8 0.1%  
BALANCE SHEET DATA
Current assets Rs m6,8521,867 367.0%   
Current liabilities Rs m6,711591 1,135.1%   
Net working cap to sales %3.3101.6 3.3%  
Current ratio x1.03.2 32.3%  
Inventory Days Days16194 170.7%  
Debtors Days Days31874 433.1%  
Net fixed assets Rs m3,6731,791 205.1%   
Share capital Rs m317534 59.3%   
"Free" reserves Rs m3,76110,324 36.4%   
Net worth Rs m4,07810,858 37.6%   
Long term debt Rs m1,67141 4,055.3%   
Total assets Rs m12,63311,591 109.0%  
Interest coverage x1.0260.9 0.4%   
Debt to equity ratio x0.40 10,798.7%  
Sales to assets ratio x0.30.1 307.8%   
Return on assets %3.414.1 24.5%  
Return on equity %0.115.0 0.8%  
Return on capital %7.715.2 50.5%  
Exports to sales %22.91.5 1,481.3%   
Imports to sales %14.321.0 68.1%   
Exports (fob) Rs m96419 4,969.1%   
Imports (cif) Rs m602263 228.6%   
Fx inflow Rs m96419 4,969.1%   
Fx outflow Rs m607264 230.1%   
Net fx Rs m357-244 -146.0%   
CASH FLOW
From Operations Rs m1,345236 570.3%  
From Investments Rs m-2,256-224 1,007.0%  
From Financial Activity Rs m-1,200-27 4,510.5%  
Net Cashflow Rs m-2,111-15 14,261.5%  

Share Holding

Indian Promoters % 4.5 64.0 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 1.4 9.7 13.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 26.1 360.5%  
Shareholders   20,807 54,701 38.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  NATCO PHARMA  ELDER PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 186 Points Higher; Energy and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day on a positive note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS